文献速递白血病淋巴瘤

SFPQ-ABL1与BCR-ABL1通过不同信号网络驱动B细胞急性淋巴细胞白血病

SFPQ-ABL1 and BCR-ABL1 use different signaling networks to drive B-cell acute lymphoblastic leukemia.
PubMed 文献 · Blood Adv · 2022-01-01

研究在一名Ph样急性淋巴细胞白血病(ALL)患儿中鉴定出罕见的SFPQ-ABL1融合,该融合表达于细胞因子依赖性细胞系足以转化细胞且对靶向ABL1的酪氨酸激酶抑制剂(TKI)敏感。与BCR-ABL1不同,SFPQ-ABL1定位于核区室且驱动细胞增殖能力较弱,磷酸化蛋白质组学显示细胞周期、DNA复制和剪接体通路上调而信号转导通路下调。SFPQ-ABL1不激活PI3K/AKT信号并与G2/M细胞周期蛋白磷酸化相关,对navitoclax和S-63845敏感并通过维持Mcl-1和Bcl-xL表达促进细胞存活。

要点

  • 在Ph样ALL患儿中鉴定出罕见的SFPQ-ABL1融合,表达于细胞因子依赖性细胞系足以转化细胞。
  • SFPQ-ABL1定位于核区室,驱动细胞增殖能力弱于BCR-ABL1。
  • SFPQ-ABL1对ABL1靶向TKI敏感,并对navitoclax和S-63845敏感。

核心结论

  • SFPQ-ABL1通过包括亚细胞定位、增殖能力和细胞通路激活在内的功能上不同的机制驱动ALL。
  • 这些发现突出融合伴侣在介导ABL1融合功能中的作用。

研究设计与样本

  • 在一名Ph样ALL患儿中鉴定出罕见SFPQ-ABL1融合。
  • 在细胞因子依赖性细胞系中表达SFPQ-ABL1进行功能研究。

主要发现

  • SFPQ-ABL1表达于细胞因子依赖性细胞系足以转化细胞,且这些细胞对靶向ABL1的TKI敏感。
  • 与BCR-ABL1不同,SFPQ-ABL1定位于核区室且为较弱的细胞增殖驱动因子。
  • 磷酸化蛋白质组学显示,与表达BCR-ABL1的细胞相比,表达SFPQ-ABL1的细胞中细胞周期、DNA复制和剪接体通路上调,信号转导通路(包括ErbB、NF-κB、血管内皮生长因子(VEGF)和MAPK信号)下调。
  • SFPQ-ABL1表达不激活磷脂酰肌醇3-激酶/蛋白激酶B(PI3K/AKT)信号,并与G2/M细胞周期蛋白磷酸化相关。
  • SFPQ-ABL1对navitoclax和S-63845敏感,并通过维持Mcl-1和Bcl-xL表达促进细胞存活。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Philadelphia-like (Ph-like) acute lymphoblastic leukemia (ALL) is a high-risk subtype of B-cell ALL characterized by a gene expression profile resembling Philadelphia chromosome-positive ALL (Ph+ ALL) in the absence of BCR-ABL1. Tyrosine kinase-activating fusions, some involving ABL1, are recurrent drivers of Ph-like ALL and are targetable with tyrosine kinase inhibitors (TKIs). We identified a rare instance of SFPQ-ABL1 in a child with Ph-like ALL. SFPQ-ABL1 expressed in cytokine-dependent cell lines was sufficient to transform cells and these cells were sensitive to ABL1-targeting TKIs. In contrast to BCR-ABL1, SFPQ-ABL1 localized to the nuclear compartment and was a weaker driver of cellular proliferation. Phosphoproteomics analysis showed upregulation of cell cycle, DNA replication, and spliceosome pathways, and downregulation of signal transduction pathways, including ErbB, NF-κB, vascular endothelial growth factor (VEGF), and MAPK signaling in SFPQ-ABL1-expressing cells compared with BCR-ABL1-expressing cells. SFPQ-ABL1 expression did not activate phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) signaling and was associated with phosphorylation of G2/M cell cycle proteins. SFPQ-ABL1 was sensitive to navitoclax and S-63845 and promotes cell survival by maintaining expression of Mcl-1 and Bcl-xL. SFPQ-ABL1 has functionally distinct mechanisms by which it drives ALL, including subcellular localization, proliferative capacity, and activation of cellular pathways. These findings highlight the role that fusion partners have in mediating the function of ABL1 fusions.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Brown LM, Hediyeh-Zadeh S, Sadras T, et al. SFPQ-ABL1 and BCR-ABL1 use different signaling networks to drive B-cell acute lymphoblastic leukemia. Blood Adv. 2022. PMID: 35061886. doi:10.1182/bloodadvances.2021006076

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。